Denovo Biopharma

About:

Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development.

Website: http://www.denovobiopharma.com/index.html

Top Investors: CICC, China Resources Pharmaceutical Group, California Institute for Regenerative Medicine, Yingke Capital, Zhejiang Paradise

Description:

Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development. The core technology is the industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples. This technology is especially useful for late stage clinical drugs that have completed trials with unsatisfactory efficacy. By identifying biomarkers correlated to patients' responsiveness to drug candidates retrospectively, our technology enables biotech and pharmaceutical companies to design new clinical trials in a targeted patient population to achieve significant efficacy and/or less adverse effects. Our platform can be broadly applied to biomarker discovery in many therapeutic areas, such as oncology, metabolic, cardiology, immunology and neurology.